Patent · US Active

Imaging and selective retention of phospholipid ether analogs

US7632644B2 · kind B2 · utility

11Cited by
7References
9Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2006
Grant dateDec 15, 2009
Priority date
Expiry dateSep 8, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/16
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention generally relates to imaging and selective retention of phospholipid ether analogs in various neoplastic tissues. Specifically, the present invention relates to imaging and methods for selective retention of analogs, for example, NM404, in cancers such as Colorectal Cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.